What are the McDonald criteria and Terblanche criteria for evaluating the outcome of a hepato‑jejunostomy and the long‑term results of biliary duct repair?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

McDonald and Terblanche Criteria for Evaluating Hepaticojejunostomy Outcomes

Terblanche Criteria

The Terblanche classification is a validated grading system used to assess long-term outcomes after hepaticojejunostomy for bile duct injury repair. This system categorizes results into distinct grades based on clinical symptoms, biochemical markers, and need for reintervention 1, 2.

Terblanche Grading System:

  • Excellent: Asymptomatic with normal liver function tests
  • Good: Asymptomatic with mildly abnormal liver function tests, or occasional episodes of cholangitis (≤2 per year) that respond to antibiotics
  • Fair: Frequent episodes of cholangitis (>2 per year) requiring antibiotics, or persistently abnormal liver function tests
  • Poor: Recurrent stricture requiring reintervention, or development of secondary biliary cirrhosis

Clinical Application:

The Terblanche criteria are specifically used to evaluate patients after biliary reconstruction, particularly following major bile duct injuries requiring hepaticojejunostomy 1. Studies demonstrate that excellent/good Terblanche grades are achieved in approximately 70-85% of patients after hepaticojejunostomy, with comparable outcomes between different surgical techniques 1, 2.

Long-term follow-up using Terblanche criteria is essential because anastomotic strictures can develop months to years after repair, with median time to stricture formation ranging from 11-30 months 3. The stricture rate after hepaticojejunostomy ranges from 10-20% in most series, though rates as high as 69% have been reported 3.

Prognostic Factors:

Factors associated with worse Terblanche outcomes include:

  • Associated vascular injury
  • Level of bile duct injury
  • Sepsis or peritonitis at presentation
  • Postoperative bile leakage
  • History of major post-transplant complications (in transplant patients) 2
  • Male gender (associated with 6.7-fold increased risk of stricture formation) 4

McDonald Criteria

The provided evidence does not contain information about McDonald criteria in the context of hepaticojejunostomy or biliary duct repair outcomes. The McDonald criteria mentioned in medical literature typically refer to diagnostic criteria for multiple sclerosis, which is unrelated to biliary surgery outcomes.

Important Clinical Caveat:

If you are seeking outcome assessment tools for hepaticojejunostomy, the Terblanche classification remains the primary validated system referenced in contemporary hepatobiliary literature 1, 2. Alternative outcome measures include:

  • Clavien-Dindo classification for postoperative complications
  • Karnofsky performance status for quality of life assessment 1
  • Primary patency rates assessed via Kaplan-Meier analysis 2

Long-term Monitoring Strategy:

Following hepaticojejunostomy, patients require:

  • Regular imaging surveillance (MRCP or PTC) to detect anastomotic strictures
  • Serial liver function tests to identify cholestasis
  • Clinical assessment for symptoms of cholangitis (fever, jaundice, abdominal pain)
  • Median follow-up of 10+ years is necessary to capture late complications including secondary biliary cirrhosis (2.4-10.9% incidence) 3, 4

Most anastomotic strictures can be successfully managed with percutaneous balloon dilatation (89% success rate), avoiding the need for reoperation in the majority of cases 4, 5.

Related Questions

In a 12‑month‑old male with normal growth and exam, which absent developmental milestone (e.g., pointing to a body part, responding to name, stacking two blocks, using a cup, or walking independently) would be most concerning and warrant further investigation?
In a 13‑day‑old infant presenting with fever and poor feeding, what interventions should emergency medical services (EMS) perform?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What are the differential diagnoses for aggressive behavior in a 10-year-old child?
In a 19-year-old college student with fever (103°F), severe headache, altered mental status, hypotension (90/55 mmHg), sluggish pupils, and leukocytosis with 20% band forms, what isolation precautions are indicated?
How can I increase my water intake safely given pelvic floor weakness, hypotension requiring a sodium supplement (Sodii), and current clonidine therapy?
In a newborn with hypoglycemia, which hormonal deficiencies should be evaluated (adrenal insufficiency, growth‑ hormone deficiency, primary hypothyroidism) and what are the initial diagnostic and treatment steps?
What is the recommended tapering schedule for clonidine 50 µg taken once daily?
How should carbimazole be used to treat maternal hyperthyroidism during pregnancy, including dosing, trimester-specific recommendations, and fetal monitoring?
Can azithromycin be used to treat acute diarrhea in a healthy patient ≥12 years old with suspected bacterial (traveler’s) infection?
Can metronidazole topical cream be used concurrently with oral doxycycline in the treatment of acne rosacea?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.